Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday?
We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other firms that ...
SoftBank adds to shares in VTEX, YMM, cuts NMRA and exits DASH, among other moves
The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...
Unusually active option classes on open February 14th
Recursion Pharmaceuticals (RXRX), Crispr Therapeutics (CRSP), iShares MSCI India (INDA), Faraday Future Intelligent Electric (FFIE), Bilibili (BILI), Procter & Gamble (PG), UP Fintech Holding Ltd ...
Hosted on MSN20h
Biotechs on the Brink: 2 Stocks With Huge Potential
Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...
Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...
Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...
Nvidia Stock Is Climbing. Amazon’s Earnings Were a Big Moment for the Chip Maker.
The chip maker got a shout out from Amazon CEO Andy Jassy on a fourth-quarter earnings call with analysts. Trump's tariffs on Canada and Mexico are delayed. Economic turmoil is here. Big Tech is a ...
SG Americas Securities LLC Reduces Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
SG Americas Securities LLC lowered its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 44.8% during the fourth quarter, HoldingsChannel reports. The firm owned 49,343 shares ...